Cargando…

Therapeutic angiogenesis in cardiovascular disease

Atherosclerotic disease of the arteries is a major cause of coronary artery disease, peripheral vascular disease and stroke. Some patients are however not candidate for the standard treatment of angioplasty or bypass surgery. Hence there is tremendous enthusiasm for the utilization of angiogenesis a...

Descripción completa

Detalles Bibliográficos
Autor principal: Al Sabti, Hilal
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169246/
https://www.ncbi.nlm.nih.gov/pubmed/18021404
http://dx.doi.org/10.1186/1749-8090-2-49
_version_ 1782144856851742720
author Al Sabti, Hilal
author_facet Al Sabti, Hilal
author_sort Al Sabti, Hilal
collection PubMed
description Atherosclerotic disease of the arteries is a major cause of coronary artery disease, peripheral vascular disease and stroke. Some patients are however not candidate for the standard treatment of angioplasty or bypass surgery. Hence there is tremendous enthusiasm for the utilization of angiogenesis as a therapeutic modality for atherosclerotic arterial disease. This augmentation of physiological neo-vascularization in cardiovascular disease can be achieved through different pathways. In this article we are reviewing the Use of Gene therapy, Protein therapy and cellular therapy.
format Text
id pubmed-2169246
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-21692462007-12-29 Therapeutic angiogenesis in cardiovascular disease Al Sabti, Hilal J Cardiothorac Surg Review Atherosclerotic disease of the arteries is a major cause of coronary artery disease, peripheral vascular disease and stroke. Some patients are however not candidate for the standard treatment of angioplasty or bypass surgery. Hence there is tremendous enthusiasm for the utilization of angiogenesis as a therapeutic modality for atherosclerotic arterial disease. This augmentation of physiological neo-vascularization in cardiovascular disease can be achieved through different pathways. In this article we are reviewing the Use of Gene therapy, Protein therapy and cellular therapy. BioMed Central 2007-11-16 /pmc/articles/PMC2169246/ /pubmed/18021404 http://dx.doi.org/10.1186/1749-8090-2-49 Text en Copyright © 2007 Al Sabti; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Al Sabti, Hilal
Therapeutic angiogenesis in cardiovascular disease
title Therapeutic angiogenesis in cardiovascular disease
title_full Therapeutic angiogenesis in cardiovascular disease
title_fullStr Therapeutic angiogenesis in cardiovascular disease
title_full_unstemmed Therapeutic angiogenesis in cardiovascular disease
title_short Therapeutic angiogenesis in cardiovascular disease
title_sort therapeutic angiogenesis in cardiovascular disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169246/
https://www.ncbi.nlm.nih.gov/pubmed/18021404
http://dx.doi.org/10.1186/1749-8090-2-49
work_keys_str_mv AT alsabtihilal therapeuticangiogenesisincardiovasculardisease